Genin A-S, Lesieur B, Gligorov J, Antoine M, Selleret L, Rouzier R. Pregnancy-associated breast cancers: Do they differ from other breast cancers in young women? The Breast. 2012;21(4):550–5.
Langer A, Mohallem M, Stevens D, Rouzier R, Lerebours F, Chérel P. A single-institution study of 117 pregnancy-associated breast cancers (PABC): Presentation, imaging, clinicopathological data and outcome. Diagn Interv Imaging. 2014;95(4):435–41.
Article CAS PubMed Google Scholar
Pentheroudakis G, Orecchia R, Hoekstra HJ, Pavlidis N. Cancer, fertility and pregnancy: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. Ann Oncol. 2010;21:v266–73.
Schedin P. Pregnancy-associated breast cancer and metastasis. Nat Rev Cancer. 2006;6(4):281–91.
Article CAS PubMed Google Scholar
Molckovsky A, Madarnas Y. Breast cancer in pregnancy: a literature review. Breast Cancer Res Treat. 2008;108(3):333–8.
Proussaloglou EM, Blanco LZ Jr, Siziopikou KP. Updates in the pathology of Pregnancy Associated Breast Cancer (PABC). Pathol Res Pract. 2023;244:154413.
Meier-Abt F, Bentires-Alj M. How pregnancy at early age protects against breast cancer. Trends Mol Med. 2014;20(3):143–53.
Husby A, Wohlfahrt J, Øyen N, Melbye M. Pregnancy duration and breast cancer risk. Nat Commun. 2018;9(1):4255.
Article PubMed PubMed Central Google Scholar
Slepicka PF, Cyrill SL, dos Santos CO. Pregnancy and Breast Cancer: Pathways to Understand Risk and Prevention. Trends Mol Med. 2019;25(10):866–81.
Janerich DT, Hoff MB. Evidence, for a crossover in breast cancer risk factors1. Am J Epidemiol. 1982;116(5):737–42.
Article CAS PubMed Google Scholar
Pilewskie M, Gorodinsky P, Fought A, Hansen N, Bethke K, Jeruss J, Scholtens D, Khan SA. Association between Recency of Last Pregnancy and Biologic Subtype of Breast Cancer. Ann Surg Oncol. 2012;19(4):1167–73.
Madaras L, Kovács KA, Szász AM, Kenessey I, Tőkés A-M, Székely B, Baranyák Z, Kiss O, Dank M, Kulka J. Clinicopathological Features and Prognosis of Pregnancy Associated Breast Cancer – A Matched Case Control Study. Pathology & Oncology Research. 2014;20(3):581–90.
Blanquisett AH, Vicent CH, Gregori JG, Zotano ÁG, Porta VG, Simón AR. Breast cancer in pregnancy: an institutional experience. Ecancermedicalscience. 2015;9:551–551.
PubMed PubMed Central Google Scholar
Azim HA Jr, Brohee S, Peccatori FA, Desmedt C, Loi S, Lambrechts D, Dell’Orto P, Majjaj S, Jose V, Rotmensz N, et al. Biology of breast cancer during pregnancy using genomic profiling. Endocr Relat Cancer. 2014;21(4):545–54.
Article CAS PubMed Google Scholar
Harvell DME, Kim J, O’Brien J, Tan A-C, Borges VF, Schedin P, Jacobsen BM, Horwitz KB. Genomic Signatures of Pregnancy-Associated Breast Cancer Epithelia and Stroma and their Regulation by Estrogens and Progesterone. Hormones and Cancer. 2013;4(3):140–53.
Article CAS PubMed PubMed Central Google Scholar
Martin M, Rodriguez-Lescure A, Ruiz A, Alba E, Calvo L, Ruiz-Borrego M, Munarriz B, Rodriguez CA, Crespo C, de Alava E, et al. Randomized phase 3 trial of fluorouracil, epirubicin, and cyclophosphamide alone or followed by Paclitaxel for early breast cancer. J Natl Cancer Inst. 2008;100(11):805–14.
Article CAS PubMed Google Scholar
Martin M, Prat A, Rodriguez-Lescure A, Caballero R, Ebbert MT, Munarriz B, Ruiz-Borrego M, Bastien RR, Crespo C, Davis C, et al. PAM50 proliferation score as a predictor of weekly paclitaxel benefit in breast cancer. Breast Cancer Res Treat. 2013;138(2):457–66.
Article CAS PubMed PubMed Central Google Scholar
Prat A, Lluch A, Turnbull AK, Dunbier AK, Calvo L, Albanell J, de la Haba-Rodríguez J, Arcusa A, Chacón JI, Sánchez-Rovira P, et al. A PAM50-based chemoendocrine score for hormone receptor positive breast cancer with an intermediate risk of relapse. Clin Cancer Res. 2017;23(12):3035–44.
Article CAS PubMed Google Scholar
Chica Parrado R, Jimenez-Rodriguez B, Sanchez Rovira P, Alvarez M, Vicioso L, Fernandez A, de Luque V, Jose Lozano M, Villar E, Zarcos I. Prosigna subtype correlation is a strong predictor of response to neoadjuvant chemotherapy (NAC) in early breast cancer (EBC) study. In: Cancer research: 2016. Philadelphia, PA: Amer Assoc Cancer Research 615 Chestnut St, 17TH floor; 2016.
Group GSBC. Proyecto El Álamo III. Encuesta de Evolución de Pacientes Con Cáncer de Mama en Hospitales del Grupo GEICAM (1998–2001). In: GEICAM Spanish Breast Cancer Group Madrid. Spain: GEICAM Spanish Breast Cancer Group Madrid; 2014.
Jara-Sanchez C, Ruiz A, Martin M, Prado PMd, Santaballa A, Llombart-Cussac A, Batista J, Pollán M, Carrasco EM, Lluch A. Spanish Breast Cancer Research Group (GEICAM) hospital-based study on breast cancer outcomes: El Álamo project (1990–2001). J Clin Oncol. 2010;28(15_suppl):e12016.
Martin M, Loibl S, von Minckwitz G, Morales S, Martinez N, Guerrero A, Anton A, Aktas B, Schoenegg W, Munoz M, et al. Phase III trial evaluating the addition of bevacizumab to endocrine therapy as first-line treatment for advanced breast cancer: the letrozole/fulvestrant and avastin (LEA) study. J Clin Oncol. 2015;33(9):1045–52.
Article CAS PubMed Google Scholar
Cejalvo JM, Martínez de Dueñas E, Galvan P, García-Recio S, Burgués Gasión O, Paré L, Antolin S, Martinello R, Blancas I, Adamo B, et al. Intrinsic subtypes and gene expression profiles in primary and metastatic breast cancer. Cancer Res. 2017;77(9):2213–21.
Article CAS PubMed PubMed Central Google Scholar
Lluch A, Barrios CH, Torrecillas L, Ruiz-Borrego M, Bines J, Segalla J, Guerrero-Zotano A, Garcia-Saenz JA, Torres R, de la Haba J, et al. Phase III Trial of Adjuvant Capecitabine After Standard Neo-/Adjuvant Chemotherapy in Patients With Early Triple-Negative Breast Cancer (GEICAM/2003-11_CIBOMA/2004-01). J Clin Oncol. 2020;38(3):203–13.
Article CAS PubMed Google Scholar
van den Broek AJ, Van’t Veer LJ, Hooning MJ, Cornelissen S, Broeks A, Rutgers EJ, Smit VT, Cornelisse CJ, Van Beek M, Janssen-Heijnen ML. Impact of age at primary breast cancer on contralateral breast cancer risk in BRCA1/2 mutation carriers. J Clin Oncol. 2016;34(5):409–18.
Denkert C, von Minckwitz G, Darb-Esfahani S, Lederer B, Heppner BI, Weber KE, Budczies J, Huober J, Klauschen F, Furlanetto J, et al. Tumour-infiltrating lymphocytes and prognosis in different subtypes of breast cancer: a pooled analysis of 3771 patients treated with neoadjuvant therapy. Lancet Oncol. 2018;19(1):40–50.
Salgado R, Denkert C, Demaria S, Sirtaine N, Klauschen F, Pruneri G, Wienert S, Van den Eynden G, Baehner FL, Penault-Llorca F, et al. The evaluation of tumor-infiltrating lymphocytes (TILs) in breast cancer: recommendations by an International TILs Working Group 2014. Ann Oncol. 2015;26(2):259–71.
Article CAS PubMed Google Scholar
Tusher VG, Tibshirani R. Chu GJPotNAoS: Significance analysis of microarrays applied to the ionizing radiation response. 2001;98(9):5116–21.
Subramanian A, Tamayo P, Mootha VK, Mukherjee S, Ebert BL, Gillette MA, Paulovich A, Pomeroy SL, Golub TR, Lander ES, Mesirov JP. Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles. Proc Natl Acad Sci U S A. 2005;102(43):15545–50.
Article CAS PubMed PubMed Central Google Scholar
Mootha VK, Lindgren CM, Eriksson K-F, Subramanian A, Sihag S, Lehar J, Puigserver P, Carlsson E, Ridderstråle M. Laurila EJNg: PGC-1α-responsive genes involved in oxidative phosphorylation are coordinately downregulated in human diabetes. Nat Genet. 2003;34(3):267–73.
Article CAS PubMed Google Scholar
Zhou Y, Zhou B, Pache L, Chang M, Khodabakhshi AH, Tanaseichuk O, Benner C, Chanda SK. Metascape provides a biologist-oriented resource for the analysis of systems-level datasets. Nat Commun. 2019;10(1):1523.
Article PubMed PubMed Central Google Scholar
Kuhn M. Building predictive models in R using the caret package. J Stat Soft. 2008;28:1–26.
Comments (0)